Clinical Trial Update: Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL. [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a conditioning regimen (busulfan, fludarabine, etoposide) for hematopoietic stem cell transplantation in children and adolescent…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• BUSULFAN (Busulfan)
• Etoposide (Etoposide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: UNKNOWN